Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: A$0.03 M
• Last 3 months FTD volume: A$24.58 M
• Last 12 months FTD volume: A$0.24 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	A$24.94 M	A$0.10 B	🇺🇸 USA
Pfizer PFE	A$56.21 M	A$0.12 B	🇺🇸 USA
AbbVie ABBV	A$49.63 M	A$98.25 M	🇺🇸 USA
Eli Lilly LLY	A$0.20 B	A$0.41 B	🇺🇸 USA
Amgen AMGN	A$0.20 B	A$0.37 B	🇺🇸 USA
Biogen BIIB	A$3.4 M	A$75.76 M	🇺🇸 USA
Illumina ILMN	A$5.36 M	A$19.75 M	🇺🇸 USA
Vertex Pharmaceuticals VRTX	A$37.95 M	A$0.10 B	🇺🇸 USA
Merck MRK	A$36.21 M	A$0.14 B	🇺🇸 USA